These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 29855362)

  • 1. The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences.
    Tsuda Y; Ogura K; Shinoda Y; Kobayashi H; Tanaka S; Kawai A
    BMC Cancer; 2018 May; 18(1):614. PubMed ID: 29855362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosticating metastatic osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate and delayed metastasectomy: a single center experience of 102 patients.
    Nataraj V; Rastogi S; Khan SA; Sharma MC; Agarwala S; Vishnubhatla S; Bakhshi S
    Clin Transl Oncol; 2016 Sep; 18(9):937-44. PubMed ID: 26742936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
    Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A
    BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma.
    Kim MS; Lee SY; Lee TR; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
    Ann Oncol; 2009 May; 20(5):955-60. PubMed ID: 19153123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and prognostic factors at time of diagnosis in high-grade appendicular osteosarcoma: a 21 year single institution evaluation from east Denmark.
    Colding-Rasmussen T; Thorn AP; Horstmann P; Rechnitzer C; Hjalgrim LL; Krarup-Hansen A; Petersen MM
    Acta Oncol; 2018 Mar; 57(3):420-425. PubMed ID: 28741397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
    Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
    BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary bone sarcomas in patients over 40 years of age: A retrospective study using data from the Bone Tumor Registry of Japan.
    Nagano A; Ishimaru D; Nishimoto Y; Akiyama H; Kawai A
    J Orthop Sci; 2017 Jul; 22(4):749-754. PubMed ID: 28412026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Expression of Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) Is Associated With a Poor Prognosis in Osteosarcoma.
    Matsuda K; Miyoshi H; Hiraoka K; Hamada T; Nakashima K; Shiba N; Ohshima K
    Clin Orthop Relat Res; 2018 Sep; 476(9):1848-1855. PubMed ID: 30024460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and prognostic factors of osteosarcoma of the jaws: a retrospective cohort study.
    Lee RJ; Arshi A; Schwartz HC; Christensen RE
    JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):470-7. PubMed ID: 25811167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling Continuous Prognostic Factors in Survival Analysis: Implications for Tumor Staging and Assessing Chemotherapy Effect in Osteosarcoma.
    Cates JMM
    Am J Surg Pathol; 2018 Apr; 42(4):485-491. PubMed ID: 29200101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes in non-metastatic treatment naive extremity osteosarcoma patients treated with a novel non-high dosemethotrexate-based, dose-dense combination chemotherapy regimen 'OGS-12'.
    Bajpai J; Chandrasekharan A; Talreja V; Simha V; Chandrakanth MV; Rekhi B; Khurana S; Khan A; Vora T; Ghosh J; Banavali SD; Gupta S
    Eur J Cancer; 2017 Nov; 85():49-58. PubMed ID: 28888849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistics of bone sarcoma in Japan: Report from the Bone and Soft Tissue Tumor Registry in Japan.
    Ogura K; Higashi T; Kawai A
    J Orthop Sci; 2017 Jan; 22(1):133-143. PubMed ID: 27847134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should High-grade Extraosseous Osteosarcoma Be Treated With Multimodality Therapy Like Other Soft Tissue Sarcomas?
    Fan Z; Patel S; Lewis VO; Guadagnolo BA; Lin PP
    Clin Orthop Relat Res; 2015 Nov; 473(11):3604-11. PubMed ID: 26197952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma.
    Thanapprapasr K; Nartthanarung A; Thanapprapasr D; Jinawath A
    PLoS One; 2017; 12(8):e0182989. PubMed ID: 28846700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postrelapse Prognostic Factors in Nonmetastatic Osteosarcoma: A Single-institution Experience.
    Berlanga P; Cañete A; Salom M; Montalar J; Guasp M; Marco A; Castel V
    J Pediatr Hematol Oncol; 2016 Apr; 38(3):176-81. PubMed ID: 26925713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
    Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
    J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pirarubicin versus doxorubicin in neoadjuvant/adjuvant chemotherapy for stage IIB limb high-grade osteosarcoma: does the analog matter?
    Yu W; Tang L; Lin F; Yao Y; Shen Z
    Med Oncol; 2015 Jan; 32(1):307. PubMed ID: 25432694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between Prognostic Factors and the Histopathological Response to Neoadjuvant Chemotherapy in Osteosarcoma: A Retrospective Study.
    Prabowo Y; Setiawan I; Kamal AF; Kodrat E; Labib Zufar ML
    Int J Surg Oncol; 2021; 2021():8843325. PubMed ID: 33996154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of postradiation osteosarcoma does not correlate with chemotherapy response.
    Lewis VO; Raymond K; Mirza AN; Lin P; Yasko AW
    Clin Orthop Relat Res; 2006 Sep; 450():60-6. PubMed ID: 16906104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
    Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
    Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.